Tech Company Financing Transactions
Verdezyne Funding Round
Verdezyne, operating out of Carlsbad, raised $6 million in funding from private investors.
Transaction Overview
Company Name
Announced On
11/29/2013
Transaction Type
Debt
Amount
$6,003,970
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2715 Loker Ave. West
Carlsbad, CA 92010
USA
Carlsbad, CA 92010
USA
Phone
Website
Email Address
Overview
Verdezyne employs its biology expertise and proprietary advanced computational algonithms to design and synthesize novel, high-diversity gene libraries for engineering proteins, metabolic pathways, and microorganisms.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Radany
Chief Financial Officer
Brian Conn
VP - Engineering
Bill Evanko
VP - General Counsel
Nancy Oleski
VP - R & D
Tom Beardslee
Browse more venture capital transactions:
Prev: 11/29/2013: Trice Medical venture capital transaction
Next: 11/29/2013: LogicSource venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document every notable VC transaction. VC investment data records on this site come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs